Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

ASTX 0.0000
price chart
Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
Outline of the Tender Offer 1) Offeror in the Public Tender Offer Autumn Acquisition Corporation 2) Company Subject to the Public Tender Offer Astex Pharmaceuticals, Inc. 3) Type of Stock that is to be Acquired All issued and outstanding shares of ...
Related articles »  
James Manuso, chairman and CEO of Astex Pharmaceuticals Inc.
Background: Manuso, a self-described �Euro mutt,� joined SuperGen Inc. as a director in 2001 and became chairman and CEO of Astex Pharma after SuperGen's acquisition last summer of Astex Therapeutics Ltd. in the U.K. The 140-employee company has ...
Pomerantz Announces Notice of Dismissal of Astex Pharmaceuticals, Inc. Class ...
NEW YORK, Nov. 11, 2014 (GLOBE NEWSWIRE) -- By order of the Delaware Court of Chancery dated November 5, 2014, the following notice is being published.
Related articles »  
Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)
In the 21st century investor's toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.
Related articles »  
5 Reasons To Buy Astex Pharmaceuticals
Astex Pharmaceuticals has established a broad pipeline of small molecule, molecularly-targeted drugs using its drug discovery engine, Pyramid, which is also used to support the company's drug discovery collaborations with leading pharmaceutical company ...
SuperGen, Inc. Changes Name To Astex Pharmaceuticals, Inc., Announces New ...
SuperGen, Inc. (NASDAQ:ASTX) announced that it has officially begun operating under the name Astex Pharmaceuticals, Inc. Concurrent with this new name, and effective at the start of trading today, September 12, 2011, the ticker symbol for the Company's ...
SuperGen changes name to Astex Pharma after deal  BusinessWeek
Related articles »  
Acquisition of Astex Pharmaceuticals, Inc. by Otsuka Pharmaceutical Co., Ltd ...
SAN DIEGO and DUBLIN, Calif., Sept. 5, 2013 /PRNewswire via COMTEX/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Astex Pharmaceuticals, Inc. ASTX ("Astex") by Otsuka Pharmaceutical Co., Ltd. ("Otsuka").
Japan's Otsuka to Buy US Cancer Drug Maker Astex for $886 Million  Wall Street Journal
Otsuka Bid for Astex Seen Undervaluing Cancer-Drug Maker  Bloomberg
Related articles »  
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in ...
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced today its plan to submit an ...
Related articles »  
Astex Pharmaceuticals: A Catalyst-Driven Year Ahead
In addition, Astex develops an Hsp90 inhibitor, AT13387, in Phase II studies for refractory gastrointestinal stromal tumors (GIST), castration resistant prostate cancer, and ALK+ lung cancer.
Related articles »  
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at ...
DUBLIN, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that detailed clinical ...
Related articles »